Encompass Health Corporation Encompass Health Corporation

Encompass Health Corporation

EHC

Rang in Aktien #1704
Encompass Health Corporation delivers a range of post-acute healthcare services... Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Aktienkurs
$127.62
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$12.59B
Veränderung (1 Tag)
-0.32%
Veränderung (1 Jahr)
2.46%
Land
US
Handel Encompass Health Corporation (EHC)

Kategorie

Healthcare
Operative Marge für Encompass Health Corporation (EHC)
Operative Marge zum October 2026 TTM: 18.00%
Laut den neuesten Finanzberichten und dem Aktienkurs von Encompass Health Corporation beträgt die aktuelle operative Marge (TTM) 18.00%. Am Ende des Jahres 2024 lag die operative Marge bei 16.09%.
Historie der operativen Marge von Encompass Health Corporation von 2000 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 18.00% 40.52%
2025 12.81% -20.39%
2024 16.09% 5.58%
2023 15.24% 5.54%
2022 14.44% -10.14%
2021 16.07% 12.77%
2020 14.25% -10.09%
2019 15.85% -0.56%
2018 15.94% -3.80%
2017 16.57% -6.86%
2016 17.79% 0.00%
2015 17.79% -9.28%
2014 19.61% 15.42%
2013 16.99% -12.24%
2012 19.36% -41.84%
2011 33.29% -49.35%
2010 65.72% 359.26%
2009 14.31% 20.25%
2008 11.90% 10.49%
2007 10.77% 52.33%
2006 7.07% -49.68%
2005 14.05% 126.25%
2004 6.21% -274.93%
2003 -3.55% -116.76%
2002 21.18% -37.11%
2001 33.68% 2.46%
2000 32.87% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
15.48% -99.14%
US
0.00% -
DE
16.80% -99.07%
US
18.67% -98.96%
SA
0.00% -
MY
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.